Societe de Promotion Pharmaceutique du Maghreb S.A. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported revenue was MAD 359.32 million compared to MAD 313.26 million a year ago. Net income was MAD 34.95 million compared to MAD 31.6 million a year ago.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
981 MAD | -0.41% | -0.48% | -1.90% |
1st Jan change | Capi. | |
---|---|---|
-1.90% | 94.19M | |
+19.62% | 43.27B | |
+24.52% | 22.92B | |
+20.29% | 15.43B | |
+7.48% | 12.95B | |
+42.51% | 11.83B | |
-8.84% | 6.91B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+13.13% | 5.55B |
- Stock Market
- Equities
- PRO Stock
- News Societe de Promotion Pharmaceutique du Maghreb S.A.
- Societe de Promotion Pharmaceutique du Maghreb S.A. Reports Earnings Results for the Half Year Ended June 30, 2022